Market participants and competition -- Regulatory and enforcement framework -- Assessing market power -- Pharmaceutical mergers -- Joint ventures and licensing agreements -- Antitrust analysis of pharmaceutical manufacturer conduct -- Antitrust issues in the distribution of pharmaceutical products -- Economists' use of data in pharmaceutical antitrust cases.
